Nosenzo John has filed 5 insider transactions across 2 companies since April 2022.
Most recent transaction: a grant/award of 3135 shares of TELA Bio, Inc. ($TELA) on June 01, 2023.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 1, 2023 | TELA Bio, Inc. | $TELA | Nosenzo John | Director | A | Common Stock | 3135 | $0.00 | 6,270.0000 | 19,185,621 | 100.00% | 0.02% |
| June 1, 2023 | TELA Bio, Inc. | $TELA | Nosenzo John | Director | A | Stock Option (Right to Buy) | 5360 | $0.00 | 5,360.0000 | 19,185,621 | 9999.99% | 0.03% |
| April 1, 2022 | Bioventus Inc. | $BVS | Nosenzo John | Fmr. Chief Commercial Officer | S | Class A Common Stock | 40 | $14.07 | 87,250.0000 | 0 | 0.05% | 0.00% |
| July 1, 2022 | Bioventus Inc. | $BVS | Nosenzo John | Fmr. Chief Commercial Officer | S | Class A Common Stock | 95 | $6.73 | 87,155.0000 | 0 | 0.11% | 0.00% |
| Oct. 3, 2022 | Bioventus Inc. | $BVS | Nosenzo John | Fmr. Chief Commercial Officer | S | Class A Common Stock | 7 | $7.00 | 87,148.0000 | 0 | 0.01% | 0.00% |